METALS, MINING AND ENERGY
Larvotto Resources (ASX: LRV) continued to deliver strong drilling results from the Metz Mining Centre within its Hillgrove Antimony-Gold Project in NSW, reinforcing confidence in the system as it advances towards upgrading the Metz Mineral Resource and Ore Reserve. Drilling identified high-grade, near-surface antimony, gold and tungsten mineralisation, extending the western extension of Metz. The presence of tungsten enhances the economic potential of the system as Larvotto builds exposure to critical minerals within its portfolio. Covered by Sydney Morning Herald and Australian Mining.
American Tungsten & Antimony (ASX: AT4) commenced refurbishment of its fully permitted Dutch Mountain tungsten processing mill in Utah, with a low-cost restart plan of approximately US$400,000 aimed at bringing the facility back into production within six months. The mill, which last processed ore from the nearby Fraction Lode mine in 2017, is expected to play a central role in restoring tungsten processing capacity in the district, supported by planned drilling at Fraction Lode to expand known mineralisation. Covered by The Australian.
Auric Mining (ASX: AWJ) delivered standout CY2025 results, reporting a 92% increase in net profit after tax to $5.2 million, alongside a 144% surge in revenue to $20.6 million. Total assets rose 61% to $34.8 million, while free cash flow climbed 129% to $6.5 million, reflecting strong operational and financial momentum. The company also marked a key milestone with the successful mining and completion of its first toll milling campaign at the Munda Gold Mine. Auric has now transitioned into a gold producer in its own right, establishing a solid platform for continued growth into 2026. Covered by The West Australian.
Iltani Resources (ASX: ILT) expects its next phase of drilling at the Orient silver-indium project in Queensland to kick off mid-April, with earthworks now underway in preparation after exploration was delayed by a long wet season. Drilling with two RC rigs is planned to comprise infill of Orient’s defined resource areas to improve resource category confidence and extensions to the known resources, plus testing other targets (Orient North, Vein 1, VTEM targets). All holes have been pegged awaiting pad preparation.
Locksley Resources (ASX: LKY) is progressing toward the production of high-purity antimony concentrate and next-generation materials, supported by ongoing advancements from its research collaboration with Rice University using material from its Mojave Project in California, USA. The program continues to deliver positive results, with optimisation efforts currently focused on achieving defence-grade antimony with purity levels exceeding 99% from Mojave-sourced material.Covered by Stockhead.
Syrah Resources (ASX: SYR) successfully completed the institutional component of its fully underwritten entitlement offer, raising approximately A$44 million at A$0.105 per share, with around 88% of entitlements taken up by existing institutional shareholders. The broader equity raising, including a fully underwritten retail component targeting a further ~A$61 million, is expected to support Syrah’s funding strategy, with new shares set to trade from early April and the retail offer open from 2 April to 17 April 2026.
Evergold Minerals (ASX: EG1) reported results from its maiden regional soil geochemical survey, completed alongside a high-resolution ground gravity survey at its Mt Monger Gold Project in WA. The combined data defined a new exploration target at the Gladiator Prospect, where a consistent north-trending gold-in-soil anomaly coincides with a newly identified gravity feature interpreted as a potential mineralised structure. This marks a significant advancement in the Company’s systematic exploration of the Mt Monger Gold Project. Covered by The Market Bull.
Lincoln Minerals (ASX: LML) received all landowner and regulatory approvals to commence Stage 1 drilling at the Minbrie Copper Project in South Australia, with a minimum 40 hole air core program scheduled for Q2 CY2026. The program will target approximately 1.7km of untested strike at Eagle Ridge within a broader 17km prospective corridor for copper and base metals, following identification of widespread mineralisation in historic drilling, including a standout intercept of 29.5m at 0.8% Cu with significant lead, zinc and silver. Results from the program will guide follow up RC and diamond drilling later in 2026. Mining.com.au, Australian Resources & Investment.
Kali Metals (ASX: KM1) identified multiple shallow, high-grade drill targets at its DOM’s Hill Gold Project in the Pilbara region, Western Australia following review of historical reports, supporting its decision to acquire the remaining 30% interest in the project. Kali also identified several new targets from early-stage aircore and rock chip samples, confirming the broad prospectivity of the DOM’s Hill tenements.
Charger Metals (ASX: CHR) provided further drilling results from Medcalf West, confirming the presence of spodumene-bearing pegmatite lodes in hole CLMRC055DT to vertical depths of 215 metres. Notable intercepts include: 6.35 metres at 1.10% Li₂O and 108ppm tantalum from 218 metres, and 4.9 metres at 0.71% Li₂O and 100ppm tantalum from 239.1 metres. Hole CLMRC055DT returned combined spodumene widths of 22.35 metres, averaging 1.36% Li₂O and 119ppm tantalum.
Chariot Resources Ltd (ASX:CC9) entered into a loan agreement with GAM Company Pty Ltd for a secured A$3.5 million loan facility. Chariot will apply the Loan primarily to repay A$2.824 million of existing debt and associated transaction costs, and may use any remaining balance for working capital. Once funded, the Loan will fully discharge the existing debt facilities and associated security, and the relevant parties will promptly lodge release documentation.
BMG Resources’ (ASX: BMG) diamond drilling is underway as part of its 10,000m resource development program at the Abercromby Gold Project in WA, targeting extensions to the existing 518,000oz gold resource which remains open at depth and along strike. The company has also scheduled a shareholder meeting on 15 April 2026 to consider a proposed name change to WA Gold, reflecting its focus on Western Australian gold assets. Covered by Business News.
Everest Metals’ (ASX: EMC) latest testwork highlights strong rubidium recovery potential at its Mt Edon Critical Minerals Project in Western Australia, with results indicating the ability to produce a marketable concentrate. The Company has also submitted its mining proposal to the WA Government, marking a key step toward development. Covered by Stockhead.
Tungsten Mining NL (ASX: TGN) will commence a 175-hole, 15,000-metre reverse circulation drilling program at its Watershed tungsten deposit in Queensland, scheduled to commence in June 2026. The program aims to further define shallow high-grade tungsten mineralisation at 20-metre spacing across five priority zones. First assay results are expected approximately six weeks after drilling begins. Results will feed into the company's ongoing Project Economic Evaluation, which is assessing accelerated development options amid record-high tungsten prices. Covered by Industry QLD.
Strong drilling results continue to extend the known mineralisation and demonstrate continuity at Andean Silver’s Cerro Bayo Silver-Gold Project in Chile. Latest assays, with grades up to 1,523g/t AgEq, support the company’s strategy to both grow and upgrade the Resource. These results will be included in the coming Resource update which will feed into restart studies.
Perpetual Resources (ASX: PEC) secured applications over 8,714 hectares of prospective tungsten exploration ground in Brazil. The company plans to commence field exploration, including mapping, resampling of historical tungsten occurrences and geochemical programs to prioritise drill targets. Covered in Stockhead.
OIL, GAS & ENERGY
NH3 Clean Energy (ASX: NH3) selected Linde Engineering as its Front End Engineering and Design (FEED) partner for the WAH2 clean ammonia project in Western Australia. Linde was appointed for its engineering capability and ammonia technology expertise. Alongside FEED delivery, the two companies will evaluate future project execution models including EPC, Build-Own-Operate, and Operations and Maintenance arrangements, with a Final Investment Decision targeted for end of 2026. Covered by Fuel Cell Network, H2View.
Cue Energy (ASX: CUE) confirmed the deadline to execute binding Gas Sales Agreements for the Mereenie and Palm Valley joint ventures was extended to 10 April 2026, following agreement with the Northern Territory’s Power and Water Corporation, providing additional time to finalise terms under the existing LOI arrangements.
RENEWABLE ENERGY
Frontier Energy (ASX: FHE) Non-Executive Director and major shareholder Grant Davey continues to back the renewable energy developer with another ~$114k purchased on market over the last week. The company continues to advance its Waroona Project in WA with debt funding for Stage One nearing completion and expected this quarter. Read the company's latest investor presentation here.
INDUSTRIALS
BPH Global (ASX: BP8) recorded gross sales of IDR 2,508,000,000 (~A$213,174) for the trading period from 15 February 2026 to 14 March 2026 based on fulfilled purchase orders with payments pending settlement under standard trading terms. In addition, it provided an update on the market on its seaweed based bio-fertilizer and bio-stimulant research and development program being conducted by Temasek Polytechnic in Singapore via TP Innovation Holdings Pte Ltd (TPIH).
TECHNOLOGY
RAS Technology (ASX: RTH) announced the appointment of highly experienced UK-based lawyer and industry expert Mr David Zeffman as a Non-Executive Director, effective 1 April 2026. The appointment marks an expansion of the Board and reflects RAS's commitment to building the expertise required to support the Company's continued growth in the Northern Hemisphere.
BIOTECH
Bioxyne (ASX: BXN) entered a manufacturing agreement with Aurora Cannabis Inc. (NASDAQ/TSX: ACB), a leading global medical cannabis company based in Canada. The initial agreement covers the supply of GMP-certified medicinal cannabis oils to the Australian market, with first deliveries already completed. The partnership is now expanding to include GMP-manufactured cannabis vape products for distribution across Australia, the United Kingdom and Germany. Covered by Australian Manufacturing & Cannabiz
Paradigm Biopharma (ASX: PAR) announced a research collaboration with City St George’s, University of London, a leading UK institution in musculoskeletal and pain research. The collaboration will investigate the effects of pentosan polysulfate sodium, Paradigm’s investigational therapy currently being evaluated in Phase 3 clinical development for knee osteoarthritis, on bone marrow lesions.
Radiopharm Theranostics (ASX: RAD) has dosed the first patient in its first-in-human Phase 1 clinical trial of RAD 402, a monoclonal antibody targeting KLK3 radiolabelled with Terbium 161 being evaluated in advanced prostate cancer. The Phase 1 clinical trial (NCT07259213) is designed to study the safety, tolerability, whole-body distribution, and preliminary clinical activity of RAD 402 in patients with advanced prostate cancer. The dose escalation Phase 1 study is designed to determine the Maximum Tolerated Dose (MTD) and/or recommended phase 2 dose (RP2D) for expansion.
Firebrick Pharma’s (ASX: FRE) Nasodine Nasal Spray has been approved by the Indonesian Government as an ‘antiseptic’ product within the ‘Household Health Supplies’ category. The approval allows importation and marketing of Nasodine Nasal Spray in Indonesia, effective immediately. Additionally, Firebrick also secured firm commitments from investors for approximately $1.5 million.
Emyria (ASX: EMD) launched a recruitment campaign for psychiatrists and therapists in Sydney, establishing its fourth state-based clinical operation under the Empax model. NSW is a strategic priority given surging mental health demand, psychological injury claims have risen 64% since 2019-20. The move extends Emyria's national workforce of 90+ trained therapists as global interest in psychedelic-assisted therapies continues to accelerate.
Arovella Therapeutics (ASX: ALA) confirmed the functionality of its novel claudin 18.2
(CLDN18.2)-targeting chimeric antigen receptor (CAR) in iNKT cells, and its IL-12-TM armouring technology has been added to demonstrate enhanced effectiveness.
CORPORATE NEWS
Sierra Nevada Gold (ASX: SNX) established a Saudi Arabian subsidiary, Arabian American Minerals LLC (AAM), marking a critical step in advancing its copper-gold exploration strategy within the Kingdom of Saudi Arabia. This milestone allows SNX to rapidly advance its flagship As Safra Copper–Gold Project, with drilling planned to commence immediately upon grant of the Exploration Licences. Covered by Stockhead and Mining Weekly.
Auric Mining (ASX: AWJ) continues to strengthen its path toward becoming a fully integrated gold producer with the key appointment of Scott Bailey to the executive role of Processing Lead to head the development and construction of the Burbanks Processing Facility. Scott is a highly experienced and well-respected mining industry professional with an extensive background in gold processing and production facility development.
Galilee Energy (ASX: GLL) appointed a US-based Advisory Board to advance its strategy to build a US-focused oil and gas exploration and production business. The four-member board will guide asset selection, drilling strategy, and capital efficiency.
Clara Resources Australia (ASX: C7A) announced a strategic repositioning centred on its 100%-owned Mareeba Gold Project, alongside a refreshed board and executive team, and the successful completion of a A$1.1 million capital raising.
Celsius Metals (ASX: CLA) appointed Bardin Davis as Managing Director and engaged an executive search firm to advise on the appointment of a Non-Executive Chair. Bardin Davis has been appointed immediately, having been a strategic advisor to the Board since January 2026.